Introduction
The mammalian liver is a vital organ, carrying out multiple critical functions, including regulation of metabolism, detoxification, bile acid synthesis, and production of blood clotting factors (Stanger, 2015) . During development, the liver is assembled from progenitor cells derived from multiple embryonic lineages and while the liver is fully functional at birth, maturation occurs during early postnatal life. Once fully formed, the liver is maintained during normal homeostasis by a relatively slow turnover of hepatocytes and other liver cell types. The mammalian liver is also characterized by its remarkable capacity for repair following injury. For example, after removal of up to two-thirds of the mouse liver, compensatory proliferation leads to restoration of liver mass within one week. Robust repair also follows hepatoxic insult from liver toxins such as acetaminophen or carbon tetrachloride. Chronic liver injury, as occurs in viral, alcohol, or diet-induced hepatitis leads to hepatocyte cell death that tolerated in part due to the ability of the liver to remove and replace damaged cells. However, chronic liver disease is also accompanied by increased risk for liver cancer suggesting the sustained activation of the regenerative response can lead to adverse consequences. Hepatocyte renewal during homeostasis, injury, and chronic disease has been attributed to distinct mechanisms ranging from an "embryonic-like" mode where activation of resident adult bipotential progenitor cells and their subsequent differentiation into hepatocytes and biliary epithelial cells recapitulates their developmental progression to and "adult" mode of self-renewal where existing hepatocytes and biliary epithelial cells re-enter the cell cycle, amplify and exit the cell cycle to replace damaged cells. Recent studies have suggested that hybrid modes of repair may also occur where hepatocytes and/or biliary epithelial cells dedifferentiate to a progenitor-like state and redifferentiate in response to appropriate stimuli. Current evidence suggests that depending on the kind, severity, and duration of injury distinct mechanisms may predominate.
Parallel and convergent studies on Hippo signaling, a conserved growth control and tumor suppressor pathway, have suggested that the Hippo pathway plays a prominent role in regulating both hepatocyte and biliary cell plasticity and connects this plasticity to development, homeostasis, regeneration and liver cancer. The Hippo signaling pathway was originally identified in the fruitfly Drosophila as a key growth and organ size regulator (Halder and Johnson, 2011; Pan, 2010) . The founding member of the pathway, Hippo, is a serine-threonine kinase that in concert with adaptor proteins such as Salvador, phosphorylates another serinethreonine kinase, Warts. When activated, Warts phosphorylates Yorkie, a transcriptional cofactor, resulting in its cytoplasmic retention and degradation. When the Hippo pathway kinases are inactive, Yorkie is not phosphorylated by Warts, enters the nucleus where it drives a program of gene expression that favors proliferation and survival. The Hippo signaling pathway is highly conserved evolutionarily with the Hippo, Warts, and Yorkie orthologs in vertebrates being Mst1/2, Lats1/2 and Yap/Taz respectively. Hippo signaling is a potent tumor suppressor pathway in the mammalian liver and also is critical for regulating hepatocyte and biliary epithelial cell fates during development. In the adult, Hippo signaling is required for proper liver regeneration and injury response and to maintain the differentiated state of hepatocytes and biliary epithelial cells. The Hippo signaling pathway is frequently deregulated in liver diseases, including in chronic liver injury and in liver cancer. In this review, the role of Hippo signaling in liver development, homeostasis and disease is reviewed with a focus on its role in regulating cellular plasticity in the hepatocyte and biliary epithelial cell lineages.
Liver cell composition and microanatomy
The major cell type of the liver is the hepatocyte that carries out many critical functions and comprises approximately 60% of the cells in the liver and about 80% of total liver mass. In addition to hepatocytes there are other specialized resident liver cells including biliary epithelial cells, Kupffer cells, stellate cells, liver sinusoidal endothelial cells as well as infiltrating lymphocytes, fibroblasts, endothelial and lymphatic cells (Krenkel and Tacke, 2017; Kubes and Jenne, 2018; Lemoinne et al., 2016; Poisson et al., 2017; Tanaka and Iwakiri, 2016; Tsuchida and Friedman, 2017; Yoo et al., 2016) . These cells are arranged in a stereotyped manner in accord with their roles in regulating essential liver functions. Hepatocytes are arranged in cords with their apical surface facing the lumen of bile canaliculi and their basal surface facing the liver sinusoids. Bile acids are secreted from the apical surface of hepatocytes where they are collected by bile ducts located at the end of the bile canalicili. Blood from the portal vein and hepatic artery flows through sinusoids in a countercurrent manner allowing for uptake and secretion of blood borne factors by hepatocytes. Specialized fenestrated liver sinusoidal endothelial cells (LSECs) line the sinusoids and facilitate exchange of materials between hepatocytes and the blood. Stellate cells are found dispersed in between hepatocytes and LSECs in the space of Disse and contribute to fibrosis in response to chronic liver injury. Kupffer cells are resident liver macrophages that patrol sinusoids and are primarily responsible for pathogen sensing and removal. Liver sinusoids are arranged into lobules, roughly hexagonal in shape, with hepatocytes radiating out from the central vein to the portal triad, composed of the portal vein, hepatic artery and bile duct. This complex mixture of cell types and tissue architecture is critical for function of the liver as a whole and is maintained during normal homeostasis as well as following regeneration and injury repair.
Liver development
The complex architecture of the liver is established during embryonic development and early postnatal stages (Ober and Lemaigre, 2018; Si-Tayeb et al., 2010) . As with other gastrointestinal organs, the liver derives from the endoderm, initially as a budding of the gut tube at around E10 in the mouse. Liver specification occurs prior to this stage from cardiac mesoderm-derived FGF and septum transversum mesenchyme-derived BMP signaling acting on the adjacent forgut endoderm. After liver bud formation, extensive proliferation drives organ growth primarily of hepatic and hematopoetic progenitor cells that are present in approximately equal numbers at mid-to late gestation. The bulk of hepatic progenitor cells at these stages are bipotential precursors of hepatocytes and biliary epithelial cells. Acquisition of the biliary epithelial cell fate is promoted by TGF-b and notch signaling emanating from developing portal regions and is accompanied by induction of key biliary epithelial transcription factors such as onecut, HNF1b, and Sox9. Hepatic progenitor cells not receiving these signals adopt a hepatocyte cell fate characterized by expression of key hepatocyte transcription factors such as HNF4a, FoxA2, and CEBPa. Single-cell transcriptome analysis of fetal liver progenitor cells suggests that hepatocyte differentiation is the default pathway for hepatoblasts and that hepatocyte lineage selection occurs between E13.5 and E15.5 in the mouse. The biliary epithelial cell fate decision also occurs early, starting at !11.5 and completed by E14.5 and is accompanied by a suppression of the hepatoblast program and acquisition of early biliary epithelial markers. Transition from the fetal to adult liver involves continued morphogenesis and maturation of hepatocytes and biliary epithelial cells as well as differentiation of bone-marrow derived Kupffer cells, hemangioblast-derived LSECs, septum transversum mesenchyme-derived portal fibroblasts and stellate cells.
In concert with these developmental signaling and gene expression programs, it has recently become appreciated that another pathway, Hippo signaling, is critical for proper hepatocyte and biliary cell development (Lee et al., 2016; Patel et al., 2017; Yi et al., 2016) . In the developing liver, the Hippo signaling pathway is dynamically regulated with intermediate levels present in developing biliary epithelial cells and heightened levels in developing hepatocytes (Lee et al., 2016; Yi et al., 2016) . Consequently, biliary epithelial cells exhibit intermediate levels of Yap activation and hepatocytes display low levels of activated Yap. This differential Yap activation is critical in both lineages: in biliary epithelial cells, Yap promotes the expression of key transcription factors such as Sox9 that reinforce the biliary epithelial cell fate whereas in hepatocytes Yap inactivation is required to allow key transcription factors such as HNF4a and FoxA2 to direct the acquisition of a mature hepatocyte gene expression profile and phenotype (Alder et al., 2014; Yimlamai et al., 2014) . How Hippo signaling is modulated differentially in hepatocytes and biliary epithelial cells is not well understood, but may result from differences in matrix composition and cellular density in periportal regions where biliary epithelial specification occurs relative to regions distant from the portal vein where hepatocytes mature.
Plasticity in liver homeostasis
Whereas the origin and fate of liver cell types during development is fairly well understood, there has been considerable debate concerning cell type origin during liver homeostasis and injury repair (Chen et al., 2017; Kopp et al., 2016; Michalopoulos, 2017; Yanger and Stanger, 2011) . In the healthy liver, hepatocyte turnover is a relatively slow process with the average life span of human hepatocytes estimated to be around 5-6 months. However, despite the relative quiescence of the liver during homeostasis, rapid hepatocyte proliferation can occur as is the case following partial hepatectomy (Michalopoulos and DeFrances, 1997) . Two distinct mechanisms (Stanger, 2015) have been proposed for homeostatic renewal of major liver cell types, including hepatocytes that differ in the cell of origin. One mechanism favors a resident stem/progenitor cell driven process whereby a distinctive biliary cell population located adjacent to periportal hepatocytes fuels hepatocyte renewal. Support for this model derives from histological observations in humans as well as genetic lineage tracing in mice (Zajicek et al., 1985; Furuyama et al., 2011; Theise et al., 1999) . However, under homeostatic conditions, several subsequent studies have shown that mature biliary epithelial cells rarely if at all undergo transdifferentiation into hepatocytes (Español-Suñer et al., 2012; Lu et al., 2015) . The second mechanism points to a model where new hepatocytes are derived from division of existing fully differentiated hepatocytes and not from an immature stem/progenitor cell population. Evidence for this model derives from lineage tracing experiments in mice that clearly demonstrate that in the uninjured liver, the majority, if not all, newly generated hepatocytes derive from preexisting hepatocytes (Malato et al., 2011) . In fact, evidence for distinct subpopulations of hepatocytes that supply new hepatocytes during homeostasis has recently been reported by using genetic fate mapping in the mouse. Both pericentral hepatocytes that express Axin2 (Wang et al., 2015) and dispersed hepatocytes that have high levels of telomerase (Lin et al., 2018) have been suggested to be responsible for homeostatic hepatocyte renewal. Whether one or the other population predominates is not clear at present and future experiments will be required to address this point.
Cellular renewal following liver injury
Part of the controversy regarding where new hepatocytes originate from during homeostasis results from studies related to liver regeneration and repair. It is generally appreciated that during liver regeneration that hepatocyte repopulation is driven by mature hepatocyte division (Michalopoulos and DeFrances, 1997) . However, in cases where hepatocyte self-renewal is impaired by liver toxins or disease, it has been thought that a facultative stem cell population becomes mobilized to contribute to hepatocyte replacement (Kopp et al., 2016; Yanger and Stanger, 2011; Chen et al., 2017) . In both humans and in rodent models, a frequent response to liver injuries that induce hepatocyte death is the formation and expansion of small progenitor-like cells adjacent to biliary ducts, termed oval cells in rodents and atypical ductular reactions in humans. Indeed, isolation and transplantation of oval cells suggest that they have the capacity to differentiate into both hepatocytes and biliary epithelial cells upon exposure to appropriate stimuli in vitro and in vivo, although their differentiation into hepatocytes is generally not very efficient (Wang et al., 2003; Suzuki et al., 2008) . These observations led to the hypothesis that oval cells (and atypical ductular cells) derive from a resident stem cell population located in the biliary epithelium that is mobilized in response to liver injury (Duncan et al., 2009; Fausto, 2004) . Attempts to identify this cell population has met with mixed results, although there does appear to be a population of biliary epithelial cells with limited ability to regenerate hepatocytes upon transplantation Shin et al., 2011) .
More recent lineage tracing studies in mice have shed light onto the relationship between hepatocytes, biliary epithelial cells and oval cells. By specific labeling of either hepatocytes or biliary epithelial cells prior to DDC (3,5-diethoxycarbonyl-1,4-dihydrocollidine) induced injury it was determined that oval cells can derive from either hepatocytes or biliary epithelial cells (Tarlow et al., 2014a; Tarlow et al., 2014b) . Biliary epithelial cell derived oval cells appear soon after injury, whereas hepatocyte-derived oval cells appear after prolonged injury. Following removal of the injury stimulus, biliary epithelial cell-derived oval cells gave rise solely to biliary epithelial cells and hepatocyte-derived oval cells gave rise exclusively to hepatocytes. Gene expression profiling of hepatocyte-derived oval cells suggested that these resemble progenitor cells, but retain a significant component of hepatocyte like gene expression patterns. It has been suggested that de-differentiation of hepatocytes may be a protective response to certain types of injury such as mediated by hepatotoxic metabolites. Hepatocyte-derived oval cells have significantly lower levels of some mature hepatocyte genes, including many cytochrome P450 genes that are responsible for generation of toxic metabolites that can lead to hepatocyte injury and death. The down-regulation of these enzymes in hepatocyte-derived oval cells presumably protects these cells by preventing accumulation of toxic metabolites. Hence, once the injury stimulus is removed, hepatocyte-derived oval cells can then redifferentiate to restore hepatocyte numbers. Underscoring the importance of hepatocytes as opposed to bile duct derived oval cells in repairing the chronically injured liver, Font-Burgada and colleagues identified a population of periportal hepatocytes that efficiently replace damaged hepatocytes (Font-Burgada et al., 2015) , suggesting that these may represent resident liver stem cells for hepatocyte renewal during chronic injury. These hepatocytes were distinct from the majority of hepatocytes in that they also expressed low levels of progenitor cell markers. Other recent cell lineage studies also support a hepatocytic origin of new hepatocytes in liver regeneration and repair (Schaub et al., 2014; Yanger et al., 2014) . Mechanistically, the hepatocyte to oval cell transition is associated with activation of the Hippo pathway cofactor Yap Lu et al., 2010) . When Yap is expressed and activated in mature hepatocytes, they de-differentiate and acquire a progenitor-like gene expression program and phenotype (Yimlamai et al., 2014) . Yap has the ability to interfere with an adult gene expression program in mature hepatocytes, in part by antagonizing key liver transcription factors such as HNF4a and FoxA2 (Alder et al., 2014) . Oval cells in general exhibit relatively high levels of Yap activation, however, whether this is a result of Hippo pathway kinase activity modulation or other means is not clear at this time. However, the observations that hepatocytes can dedifferentiate to progenitor-like cells upon Yap activation likely reflects the essential role of Hippo signaling during hepatocyte development.
Studies of mouse oval cell origin and fate highlight the potential for plasticity in the hepatocyte lineage but also emphasize the restricted lineage potential of these cells. However, recent studies indicate an extended capacity of both hepatocytes and biliary epithelial cells to switch fates upon appropriate stimuli. Biliary epithelial cells generally do not contribute to hepatocyte renewal in mouse models of liver injury (Español-Suñer et al., 2012; Lu et al., 2015) , however, if hepatocyte proliferation is blocked, biliary epithelial cells have the capacity to form hepatocytes in response to hepatocyte injury (Lu et al., 2015; Raven et al., 2017) either by transdifferentiation or by activation of a resident facultative stem cell population. These mechanisms may also be operating in the human liver as chronic liver disease generally leads to diminished capacity for hepatocyte self-renewal to a greater extent that is observed in standard mouse injury models. Biliary to hepatocyte conversion is also seen in regenerating zebrafish livers where after severe liver injury (removal of >90% of hepatocytes) hepatocyte repopulation is fueled by transdifferentiation of biliary epithelial cells (Choi et al., 2014; He et al., 2014) . Hepatocytes can also convert to biliary epithelial or biliary epithelial-like cells. For example, activation of the notch signaling pathway in mature hepatocytes induces their transition to a biliary epithelial cell phenotype (Yanger et al., 2013) . Hepatocytes are also able to reconstruct the biliary system de novo in situations where normal biliary formation during development is blocked (Schaub et al., 2018) . Apparently, this route of biliary epithelial cell formation is distinct from the notchdependent pathway taken by hepatoblasts during development as notch signaling is not required. Taken together, these studies highlight the plasticity that is inherent in biliary epithelial cells and hepatocytes, likely a reflection of their common developmental origin.
Applications to regenerative medicine
The observation that liver cells, including hepatocytes and biliary epithelial cells, can reversibly de-differentiate to a progenitor-like state has implications for the treatment and prevention of liver disease. End-stage liver disease caused by inherited metabolic disorders or by environmental insults (viral and/or diet-induced hepatitis) can presently only be cured by organ transplant. Cell replacement and/or gene therapy has been proposed as alternative approaches to extend survival and/or replace transplantation as a curative option for treatment of end stage liver disease (Alwahsh et al., 2018; Tolosa et al., 2016) . However, one obstacle to these approaches has been the inability to culture and expand hepatocytes in vitro. In general, when hepatocytes are isolated and cultured in vitro, they rapidly lose their differentiated phenotype and do not efficiently proliferate. Conversely, efforts to generate hepatocytes from induced pluripotent stem cells (iPSCs) have been hampered by a lack of iPSCderived hepatocytes to acquire a fully mature phenotype in vitro or in vivo. The observation that differentiated hepatocytes have the capacity to undergo reversible dedifferentiation and acquisition of progenitor cell-like properties in vivo has prompted efforts to recapitulate these effects in vitro for the purpose of hepatocyte expansion and cell-based therapy for liver diseases. Several recent reports suggest that this is a promising approach. For example, specific combinations of small molecules can reprogram mature hepatocytes to a progenitor-like state in vitro and these hepatocytes retain their capability to fully differentiate upon transplantation to the liver (Katsuda et al., 2017; Wu et al., 2017) . Another approach is to isolate and expand adult bipotential liver stem cells (Huch et al., 2015) . Although it is unclear whether these adult liver stem cells are responsible for homeostatic renewal or injury repair in vivo, they may nevertheless be useful for ex vivo expansion and transplantation where they have the capacity to differentiate into both biliary epithelial cells and hepatocytes. While these reports are encouraging, there are many obstacles to overcome before cell-based liver therapies are to be used in the clinic. In general, transplanted hepatocytes do not efficiently repopulate intact livers unless they have a selective advantage over host hepatocytes. To address this issue Yovchev and coworkers transduced hepatocytes that were engineered to express a tamoxifen-inducible Yap cDNA enabling them to repopulate undamaged rat livers in vivo in a tamoxifen dependent manner (Yovchev et al., 2016) . Small molecule-induced mature hepatocyte reprogramming has been demonstrated for rodent cells but suitable conditions for reversible reprogramming of human cells have not been optimized. Additionally, there are concerns regarding genome stability of cultured hepatocytes or hepatic stem cells and whether this might contribute to hepatocarcinogenesis after long-term adoptive transfer. Finally, cell-based therapies are likely to be most applied in the context of chronically damaged livers and whether hepatocytes from these individuals can be efficiently reprogrammed or whether they can repopulate and differentiate effectively in the context of damaged livers remains to be determined.
Liver cancer
Chronic liver injury is a significant risk factor for the development of liver cancer. Indeed, the majority of hepatocellular carcinoma patients present with a history of chronic liver disease resulting from viral infection or non-alcoholic steatohepatitis (Llovet et al., 2016) . Chronic liver disease produces scarring and fibrosis, hepatocyte death, persistent hepatocyte compensatory proliferation, and immune infiltration. Each of these events likely contributes to transformation of normal liver cells to liver cancer cells by both cell intrinsic mechanisms and by modulating the tissue microenvironment. Since the incidence of liver cancer is increasing and most patients are diagnosed at late stages with limited treatment options, prognosis is poor with average overall survival rates of 15-17 months for the majority of patients. Hence there is considerable interest in defining mechanisms that promote malignant transformation of liver cells with the idea that understanding these mechanisms will enable the identification and development of new targeted therapies for liver cancer.
An important question in the study of liver cancer initiation and progression is what is the cell of origin for different types of liver cancers. In humans, the majority of liver cancers are classified as hepatocellular carcinomas (80%) followed by cholangiocarcinomas (15%) and other more rare types (hepatoblastoma, fibrolamellar hepatocellular carcinoma). As their names imply, hepatocellular carcinomas cells more resemble hepatocytes in terms of their morphology and gene expression programs, while cholangiocarcinomas more resemble biliary epithelial cells. Hence, it is generally thought that hepatocellular carcinomas derive from hepatocytes and cholangiocarcinomas derive from biliary epithelial cells (Marquardt et al., 2015) . Lineage tracing experiments in genetically and diet-induced hepatocellular carcinoma suggest that the cell of origin is indeed mature hepatocytes (Mu et al., 2015) . An alternative hypothesis that hepatocellular carcinoma cells derive from liver progenitor or oval cells has also been proposed. Indeed, isolated liver progenitor cells have the capability when transduced by potent oncogenes such as SV40 large T to form hepatocellular carcinomas when transplanted into host livers at a greater efficiency than either mature hepatocytes or biliary epithelial cells transduced with the same oncogenes (Holczbauer et al., 2013) . However, while induced liver progenitor cells, presumably derived from biliary epithelial cells can form hepatocellular carcinoma under certain experimental situations, careful fate mapping of liver progenitor cells and hepatocytes in situ indicates that this is not the case in a variety of mouse models that have been studied to date (Jörs et al., 2015; Shin et al., 2016) . Hence, while biliary epithelial cells have been shown to be able to give rise to cells with bipotential progenitor phenotypes that have the ability to interconvert to hepato-cytes in some injury situations, apparently these cells are not the source of hepatocellular carcinoma in well-studied animal models. In contrast, cholangiocarcinoma can originate from either mature hepatocytes or from mature biliary epithelial cells (Fan et al., 2012; Guest et al., 2014; Tschaharganeh et al., 2016; Sekiya and Suzuki, 2012) . Persistent and high levels of notch activation in mature hepatocytes can cause them to adopt a biliary phenotype and to form cholangiocarcinomas in combination with activated Akt. Loss of p53 in murine hepatocytes facilitates their dedifferentiation and in combination with additional oncogenic drivers can result in either hepatocellular carcinoma or cholangiocarcinoma. Deletion of p53 in biliary epithelial cells in combination with the hepatotoxin thioacetamide also results in cholangiocarcinoma suggesting that biliary cells are the cell of origin in this case. Whether there is a distinction between hepatocyte or biliary epithelial derived cholangiocarcinoma in terms of aggressiveness or treatment response in these preclinical models has not been defined. Additionally, while experimental models suggest that cholangiocarcinomas can originate from transformation of either hepatocytes or biliary epithelial cells, whether this also occurs with any frequency in humans remains to be determined.
Mature hepatocytes are normally quiescent but have the capability for essentially unlimited proliferation after partial hepatectomy or serial transplantation (Michalopoulos and DeFrances, 1997) . In these contexts, hepatocyte proliferation is transient, with cells returning to a quiescent state once homeostasis has been restored. In the case of malignant transformation, liver cancer cells have lost the ability to respond to normal homeostatic mechanisms and hence proliferate unchecked. Understanding these mechanisms is important in discovering and developing new treatments for liver cancer. Intensive sequencing efforts have revealed the genetic landscape of hepatocellular carcinoma and many genes and pathways are altered in cancer cells that likely contribute to the malignant phenotype (Ally et al., 2017) . Additional oncogenic and/or tumor suppressor pathways that contribute to liver cancer progression are deregulated not by mutation, but by other epigenetic mechanisms. Among these pathways is the Hippo signaling pathway that is altered in approximately 30% of human hepatocellular carcinomas and correlated with poor clinical prognosis (Xu et al., 2009 ). Deregulation of Hippo signaling is observed in a variety of chronic liver injuries, including in non-alcoholic fatty liver disease, cholestasis, and viral infection (Bai et al., 2012; Machado et al., 2015; Wang et al., 2016; Zhang et al., 2012) . In addition, the Hippo pathway transcription factor Yap is activated rapidly following partial hepatectomy and is required for a robust regenerative response (Grijalva et al., 2014; Lu et al., 2018) . These observations have led to the idea that modulation of the Hippo/Yap pathway is an adaptive response to liver injury and that persistent Hippo path-way inactivation/Yap activation contributes to liver cancer progression. Mechanistically, Yap has several protective and oncogenic effects when expressed in mature hepatocytes. Normally, the Hippo pathway is active in mature hepatocytes where it phosphorylates Yap (and Taz) thereby promoting their degradation and cytoplasmic localization. When Hippo pathway components are inactivated or when Yap is overexpressed, Yap (and Taz) enter the nucleus and drive hepatocyte proliferation and survival. Additionally, Yap induces de-differentiation of mature hepatocytes by inhibiting activities of key liver transcription factors such as HNF4a and FoxA2 (Alder et al., 2014; Cai et al., 2017; Yimlamai et al., 2014) . The function of the Hippo signaling pathway in this context is opposite of what its role in liver development where Hippo signaling is upregulated to inactivate Yap and Taz in hepatocytes. When activated inappropriately in mature hepatocytes, Yap and Taz also regulate the expression of secreted factors that regulate the tissue microenvironment in the liver to promote hepatocarcinogenesis by activating hepatic stellate cells that cause fibrosis and by recruiting and/or activating myeloid tumor suppressor cells resulting in immune suppression and escape of tumor cells from immune surveillance Kim et al., 2018; Wang et al., 2016) . In the short term these responses are likely helpful in tissue repair by aiding clearance of damaged cells and reducing liver injury. However, chronic Yap and Taz activation has adverse consequences and contributes to liver disease progression. Hence, the Hippo signaling pathway and its transcriptional regulators Yap and Taz are key regulators of hepatocyte plasticity and of the tissue microenvironment that are deregulated in hepatocellular carcinoma.
Conclusion
The mammalian liver is a relatively quiescent organ during tissue homeostasis. Cellular renewal under these conditions is typified by lineage restricted renewal by mature cells and not by multipotent stem cell activation or transdifferentiation. However, upon injury there is rapid mobilization and proliferation of a variety of resident and non-resident cell types that contributes to injury resolution and repair and depending on the injury type and duration and can involve extensive cellular plasticity, especially between hepatocytes and biliary epithelial cells. Chronic injury predisposes to more serious conditions such as liver cancer in part by activating these plasticity mechanisms and modulation of the tissue microenvironment. Understanding mechanisms that underlie cellular plasticity, including the Hippo/Yap signaling pathway, are providing new approaches for manipulating liver cell fates for regenerative therapies and for treatment of liver diseases such as liver cancer.
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